A scientific paper reviews the latest advancements in Amphotericin-B's new
formulations. These advances will help with the treatment of human
infections.



Amphotericin-B (Am-B) is a well-known therapeutic drug for various human
infections, such as fungal and parasitic pathogens. However, Am-B's new
formulations have caused certain issues in their clinical application.
That's why proper scientific design is necessary to produce safe and
effective delivery systems.



Researchers reviewed the novel drug delivery systems that can help minimize
issues for Am-B. The features that they studied include liposomes,
lipo-polymersomes, dendrimers, emulsions, nanocapsules, nanocochleate,
cyclodextrins, polymeric micelles, mixed micelles, polymer and protein-based
nanostructured materials, drug conjugates and microneedles. These features
display promising outcomes for treating different human systemic infections.



[onlinelibrary.wiley.com]